Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People

NCT01162889 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

70

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Healthy

Interventions

DRUG: Placebo SC Injection
DRUG: ATR-107 (PF-05230900) SC Injection
DRUG: ATR-107 (PF-05230900) SC Injection
DRUG: ATR-107 (PF-05230900) SC Injection
DRUG: ATR-107 (PF-05230900) SC Injection
DRUG: ATR-107 (PF-05230900) SC Injection
DRUG: ATR-107 (PF-05230900) IV Infusion
DRUG: ATR-107 (PF-05230900) IV Infusion
DRUG: ATR-107 (PF-05230900) IV Infusion
DRUG: Placebo IV Infusion
DRUG: ATR-107 (PF-05230900) IV Infusion

Sponsor

Pfizer